Understand Every Side.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Manchester City
Baseball
Social Media
NBA
Wrestling
South America
Soccer
Artificial Intelligence
Natural Disasters
Military
Instagram
Published • loading... • Updated

Novel Hepatitis B Vaccines Show Promise in Phase 1a Study: Safety and Immunogenicity Results for GS-2829 and GS-6779

Summary by contagionlive.com
Therapeutic vaccines GS-2829 and GS-6779 demonstrate immune responses and strong safety profile, showing potential to contribute to global hepatitis B elimination efforts.

1 Articles

All
Left
Center
Right
contagionlive.comcontagionlive.com

Novel Hepatitis B Vaccines Show Promise in Phase 1a Study: Safety and Immunogenicity Results for GS-2829 and GS-6779

Therapeutic vaccines GS-2829 and GS-6779 demonstrate immune responses and strong safety profile, showing potential to contribute to global hepatitis B elimination efforts.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

contagionlive.com broke the news in on Wednesday, May 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccines

Vaccines

News
For You
SearchBlindspotLocal